Ligand Pharmaceuticals Inc: Form 8-K, filed Jun 25, 2026
Filed with the SEC on Jun 25, 2026 and accepted by EDGAR at Jun 25, 2026, 17:00 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.03 New direct financial obligation
- Item 3.02 Unregistered sale of equity
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-282990. Last ingested by Listed: Oct 29, 2026, 07:16 ET. Listed shows no prices and gives no investment advice.